$NLTX

Neoleukin Therapeutics Inc

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Pharmaceuticals: Major
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$1.06 ▼-4.505%

Last Close

VOLUME

143,365

DAY RANGE

1 - 1.14

52 WEEK

0.9234 - 11.1

Join Discuss about NLTX with like-minded investors

profile
@dros #droscrew
recently

+Initiations 1/6: $ARDX $AYX $DNMR $KDNY $LAZR $NBTX $NLTX $OPEN $PTGX $SCYX $SEIC $SRRK $VINC $VLDR $VSTO $WELL . -Initiations 1/6: $SCCO

59 Replies 13 👍 10 🔥

Key Metrics

Market Cap

45.05 M

Beta

1.74

Avg. Volume

300.14 K

Shares Outstanding

42.50 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-04

Next Dividend Date

Company Information

Neoleukin is a biopharmaceutical company creating next generation immunotherapies for cancer, inflammation and autoimmunity using de novo protein design technology. Neoleukin uses sophisticated computational methods to design proteins that demonstrate specific pharmaceutical properties that provide potentially superior therapeutic benefit over native proteins. Neoleukin's lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to improve tolerability and activity by eliminating the alpha receptor binding interface.

Website:

HQ: ,

Related News